Notice of Closed Meeting, 75287-75288 [2023-24240]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341.
Telephone: (404) 639–0913; Email:
MWalters@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
and Prevention, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia
30341. Telephone: (770) 488–1504;
Email: CGentles@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE24–030, Research Grants for
Preventing Violence and Violence
Related Injury (R01).
Dates: April 2–3, 2024.
Times: 8:30 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, Pharm.D., B.C.P.S.,
C.D.C.E.S., Scientific Review Officer,
National Center for Injury Prevention
and Control, Centers for Disease Control
Jkt 262001
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–24239 Filed 11–1–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
16:32 Nov 01, 2023
Georgia 30341. Telephone: (404) 639–
0913; Email: MWalters@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2023–24241 Filed 11–1–23; 8:45 am]
[FR Doc. 2023–24242 Filed 11–1–23; 8:45 am]
VerDate Sep<11>2014
75287
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE22–003, Rigorously Evaluating
Programs and Policies to Prevent Child
Sexual Abuse (CSA).
Date: April 11, 2024.
Time: 8:30 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel L. Walters, Ph.D., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease and Prevention, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
CE24–012, Rigorous Evaluation of
Policy-Level Interventions to Prevent
Overdose.
Date: March 26, 2024.
Time: 8:30 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341.
Telephone (404) 639–6473; Email:
AWilkes@cdc.gov.
E:\FR\FM\02NON1.SGM
02NON1
75288
Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–24240 Filed 11–1–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Performance Review Board
Membership
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services.
ACTION: Notice of Performance Review
Board membership.
AGENCY:
khammond on DSKJM1Z7X2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Lei
Lonni Giroux, 410–786–4175 or
leilonni.giroux@cms.hhs.gov.
The statutes at 5 U.S.C. 4314(c)(1)
through (5) require each agency to
establish, in accordance with
regulations prescribed by the Office of
Personnel Management, one or more
Senior Executive Service (SES)
Performance Review Boards (PRBs).
The PRB shall review and evaluate
the initial summary rating of a senior
executive’s performance, the executive’s
response, and the higher-level official’s
comments on the initial summary
rating. In addition, the PRB will review
and recommend executive performance
bonuses and pay increases.
The statutes at 5 U.S.C. 4314(c)(4)
require the appointment of board
members to be published in the Federal
Register. The following persons
comprise a standing roster to serve as
members of the SES PRB for the Centers
for Medicare & Medicaid Services:
Jonathan Blum, Principal Deputy
Administrator and Chief Operating
Officer (serves as the Chair)
Tia Butler, Director, Office of Human
Capital (serves as co-chair)
VerDate Sep<11>2014
16:32 Nov 01, 2023
Jkt 262001
John Czajkowski, Deputy Chief
Operating Officer
Elizabeth Fowler, Deputy Administrator
and Director, Center of Medicare and
Medicaid Innovation
Jeffrey Wu, Deputy Director for
Operations, Center for Consumer
Information and Insurance Oversight
Timothy Engelhardt, Director, Federal
Coordinated Health Care Office
George Hoffman, Deputy Director, Office
Information Technology and Deputy
Chief Information Officer
Kathleen Cantwell, Office of Strategic
Operations and Regulatory Affairs
Jean Moody-Williams, Deputy Director,
Center for Clinical Standards and
Quality
Ing-Jey Cheng, Director, Chronic Care
Policy Group, Center for Medicare
The Deputy Administrator and Chief
Operating Officer of the Centers for
Medicare & Medicaid Services (CMS),
Jonathan Blum, having reviewed and
approved this document, authorizes
Evell Barco Holland, who is the Federal
Register Liaison, to electronically sign
this document for purposes of
publication in the Federal Register.
Dated: October 27, 2023.
Evell Barco Holland,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2023–24162 Filed 10–30–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Advance Planning Document
(APD) Process (Office of Management
and Budget #0970–0417)
Office of Child Support
Services, Administration for Children
and Families, United States Department
of Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
Child Support Services (OCSS) is
requesting a 3-year extension for the
Advance Planning Document (APD)
process (OMB #0970–0417). No changes
are proposed.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Description: State child support
agencies are required to establish and
operate a federally approved statewide
Automated Data Processing (ADP) and
information retrieval system to assist in
child support services. The APD
process, established at 45 CFR part 95,
subpart F, is the procedure by which
states request and obtain approval for
Federal Financial Participation (FFP) in
their cost of acquiring ADP equipment
and services. The ACF OCSS Division of
State and Tribal Systems (DSTS)
oversees this process.
States are required to submit an initial
APD, containing information to assist
the Secretary of the Department of
Health and Human Services (HHS) in
determining if the state computerized
support enforcement project planning
and implementation meets Federal
certification requirements needed for
the approval of FFP. States are then
required to submit annual APD updates
to HHS to report project status and
request ongoing FFP for systems
development, enhancements,
operations, and maintenance. Asneeded APDs are also submitted to
acquire FFP when major milestones are
missed or significant changes to project
schedules occur. Based on an
assessment of the information provided
in the APD, states that do not meet the
Federal requirements necessary for
approval are required to conduct
periodic independent verification and
validation services for high-risk project
oversight.
In addition to the APDs providing
HHS/ACF/OCSS with the information
necessary to determine the allowable
level of Federal funding for state
systems projects, states also submit
associated procurement and data
security documents, such as requests for
proposals (RFPs), contracts, contract
amendments, and the biennial security
review reports.
Respondents: State child support
agencies.
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 88, Number 211 (Thursday, November 2, 2023)]
[Notices]
[Pages 75287-75288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24240]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-CE24-012, Rigorous Evaluation of
Policy-Level Interventions to Prevent Overdose.
Date: March 26, 2024.
Time: 8:30 a.m.-5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Aisha L. Wilkes, M.P.H.,
Scientific Review Officer, National Center for Injury Prevention and
Control, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. Telephone (404)
639-6473; Email: [email protected].
[[Page 75288]]
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-24240 Filed 11-1-23; 8:45 am]
BILLING CODE 4163-18-P
